Number of the records: 1  

Recombinant, structually unique Kazal-type proteinase inhibitor retains activity when C-terminally extended and glycosylated

  1. 1.
    0022123 - ENTU-I 2006 RIV US eng J - Journal Article
    Kludkiewicz, B. - Kodrík, Dalibor - Grzelak, K. - Nirmala, X. - Sehnal, František
    Recombinant, structually unique Kazal-type proteinase inhibitor retains activity when C-terminally extended and glycosylated.
    [Rekombinantní, strukturně ojedinělý proteázový inhibitor Kazalova typu zůstává aktivní po prodloužení karboxylového konce a glykozylaci.]
    Protein Expression and Purification. Roč. 43, č. 2 (2005), s. 94-102. ISSN 1046-5928. E-ISSN 1096-0279
    R&D Projects: GA AV ČR(CZ) IBS5007316
    Grant - others:Centre of Excellence in Molecular Biology at the Institute of Biochemistry and Biophysics(BE) ICA-CT-2000-700010; NATO(BE) LST.CLG.979223
    Institutional research plan: CEZ:AV0Z50070508
    Keywords : fusion proteins * glycosylation * Kazal domain
    Subject RIV: CE - Biochemistry
    Impact factor: 1.553, year: 2005

    Permanent Link: http://hdl.handle.net/11104/0110913
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.